Nisa Investment Advisors LLC Has $172,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

Nisa Investment Advisors LLC lowered its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 31.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,588 shares of the company’s stock after selling 1,174 shares during the quarter. Nisa Investment Advisors LLC’s holdings in HealthEquity were worth $172,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. BlackRock Inc. lifted its stake in shares of HealthEquity by 4.0% during the first quarter. BlackRock Inc. now owns 9,423,008 shares of the company’s stock valued at $635,488,000 after acquiring an additional 358,743 shares during the period. Vanguard Group Inc. lifted its stake in shares of HealthEquity by 0.4% during the third quarter. Vanguard Group Inc. now owns 8,173,889 shares of the company’s stock valued at $549,041,000 after acquiring an additional 31,009 shares during the period. Wasatch Advisors Inc. lifted its stake in shares of HealthEquity by 3.3% during the first quarter. Wasatch Advisors Inc. now owns 7,638,935 shares of the company’s stock valued at $515,170,000 after acquiring an additional 244,868 shares during the period. FMR LLC lifted its stake in shares of HealthEquity by 19.1% during the third quarter. FMR LLC now owns 5,648,992 shares of the company’s stock valued at $412,659,000 after acquiring an additional 907,743 shares during the period. Finally, State Street Corp lifted its stake in shares of HealthEquity by 2.4% during the second quarter. State Street Corp now owns 2,816,282 shares of the company’s stock valued at $177,820,000 after acquiring an additional 65,809 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 2,558 shares of the stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $82.59, for a total transaction of $211,265.22. Following the completion of the transaction, the executive vice president now directly owns 47,438 shares in the company, valued at $3,917,904.42. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CEO Jon Kessler sold 33,765 shares of the stock in a transaction dated Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the transaction, the chief executive officer now directly owns 126,635 shares in the company, valued at $10,106,739.35. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Delano Ladd sold 2,558 shares of the stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the transaction, the executive vice president now owns 47,438 shares of the company’s stock, valued at $3,917,904.42. The disclosure for this sale can be found here. Over the last three months, insiders sold 71,322 shares of company stock worth $5,682,895. 2.70% of the stock is owned by corporate insiders.

HealthEquity Stock Up 1.3 %

Shares of HealthEquity stock opened at $80.89 on Friday. HealthEquity, Inc. has a 1 year low of $48.86 and a 1 year high of $84.49. The business has a 50-day moving average of $81.08 and a two-hundred day moving average of $74.26. The company has a market capitalization of $6.94 billion, a P/E ratio of 126.39, a price-to-earnings-growth ratio of 1.30 and a beta of 0.53. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. The business had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. As a group, equities analysts predict that HealthEquity, Inc. will post 2.12 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Barclays upped their price objective on HealthEquity from $84.00 to $104.00 and gave the company an “overweight” rating in a report on Friday, February 23rd. JPMorgan Chase & Co. upped their price objective on HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a report on Tuesday, April 2nd. Bank of America upped their price objective on HealthEquity from $93.00 to $97.00 and gave the company a “buy” rating in a report on Wednesday, March 20th. BTIG Research upped their price objective on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, March 20th. Finally, Royal Bank of Canada upped their price objective on HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, March 20th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $96.17.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.